160 related articles for article (PubMed ID: 10575321)
1. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women.
Vadgama JV; Wu Y; Datta G; Khan H; Chillar R
Oncology; 1999 Nov; 57(4):330-40. PubMed ID: 10575321
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor (IGF)-I and IGF binding protein-3 in relation to terminal duct lobular unit involution of the normal breast in Caucasian and African American women: The Susan G. Komen Tissue Bank.
Oh H; Pfeiffer RM; Falk RT; Horne HN; Xiang J; Pollak M; Brinton LA; Storniolo AMV; Sherman ME; Gierach GL; Figueroa JD
Int J Cancer; 2018 Aug; 143(3):496-507. PubMed ID: 29473153
[TBL] [Abstract][Full Text] [Related]
3. Genetic, anthropometric, and lifestyle factors associated with IGF-1 and IGFBP-3 levels in Hispanic and non-Hispanic white women.
Slattery ML; Baumgartner KB; Byers T; Guiliano A; Sweeney C; Herrick J; Curtin K; Murtaugh M; Wolff R
Cancer Causes Control; 2005 Dec; 16(10):1147-57. PubMed ID: 16215864
[TBL] [Abstract][Full Text] [Related]
4. Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk.
Jernström H; Chu W; Vesprini D; Tao Y; Majeed N; Deal C; Pollak M; Narod SA
Mol Genet Metab; 2001 Feb; 72(2):144-54. PubMed ID: 11161840
[TBL] [Abstract][Full Text] [Related]
5. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I (IGF-I) and IGF-binding proteins blood serum levels in women with early- and late-stage breast cancer: mutual relationship and possible correlations with patients' hormonal status.
Favoni RE; de Cupis A; Perrotta A; Sforzini S; Amoroso D; Pensa F; Miglietta L
J Cancer Res Clin Oncol; 1995; 121(11):674-82. PubMed ID: 7593132
[TBL] [Abstract][Full Text] [Related]
7. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
[TBL] [Abstract][Full Text] [Related]
8. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States.
Elledge RM; Clark GM; Chamness GC; Osborne CK
J Natl Cancer Inst; 1994 May; 86(9):705-12. PubMed ID: 7908990
[TBL] [Abstract][Full Text] [Related]
9. Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest.
Rollison DE; Giuliano AR; Risendal BC; Sweeney C; Boulware D; Laronga C; Baumgartner KB; Byers T; Slattery ML
Breast Cancer Res Treat; 2010 Jun; 121(3):661-9. PubMed ID: 19888649
[TBL] [Abstract][Full Text] [Related]
10. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.
Duggan C; Wang CY; Neuhouser ML; Xiao L; Smith AW; Reding KW; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard-Barbash R; McTiernan A
Int J Cancer; 2013 Mar; 132(5):1191-200. PubMed ID: 22847383
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 following chemotherapy for advanced breast cancer.
Holdaway IM; Mason BH; Lethaby AE; Singh V; Harvey VJ; Thompson PI; Evans BD
ANZ J Surg; 2003 Nov; 73(11):905-8. PubMed ID: 14616567
[TBL] [Abstract][Full Text] [Related]
12. Serum IGF-1, IGFBP-3 levels and circulating tumor cells (CTCs) in early breast cancer patients.
Papadakis GZ; Mavroudis D; Georgoulias V; Souglakos J; Alegakis AK; Samonis G; Bagci U; Makrigiannakis A; Zoras O
Growth Horm IGF Res; 2017 Apr; 33():28-34. PubMed ID: 28258988
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 blood levels in breast cancer.
Hartog H; Boezen HM; de Jong MM; Schaapveld M; Wesseling J; van der Graaf WT
Breast; 2013 Dec; 22(6):1155-60. PubMed ID: 23968866
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.
; Key TJ; Appleby PN; Reeves GK; Roddam AW
Lancet Oncol; 2010 Jun; 11(6):530-42. PubMed ID: 20472501
[TBL] [Abstract][Full Text] [Related]
15. Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort.
Rinaldi S; Biessy C; Hernandez M; Lesueur F; dos-Santos-Silva I; Rice MS; Lajous M; Lopez-Ridaura R; Torres-Mejía G; Romieu I
Int J Cancer; 2014 Mar; 134(6):1436-44. PubMed ID: 24037648
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: a report from the Shanghai Breast Cancer Study.
Deming SL; Ren Z; Wen W; Shu XO; Cai Q; Gao YT; Zheng W
Breast Cancer Res Treat; 2007 Sep; 104(3):309-19. PubMed ID: 17063263
[TBL] [Abstract][Full Text] [Related]
17. Racial differences in the association between body mass index and serum IGF1, IGF2, and IGFBP3.
Fowke JH; Matthews CE; Yu H; Cai Q; Cohen S; Buchowski MS; Zheng W; Blot WJ
Endocr Relat Cancer; 2010 Mar; 17(1):51-60. PubMed ID: 19786462
[TBL] [Abstract][Full Text] [Related]
18. Influence of droloxifene on plasma levels of insulin-like growth factor (IGF)-I, Pro-IGF-IIE, insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 in breast cancer patients.
Helle SI; Anker GB; Tally M; Hall K; Lønning PE
J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):167-71. PubMed ID: 8645625
[TBL] [Abstract][Full Text] [Related]
19. Serum insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and risk of breast cancer in the Japan Collaborative Cohort study.
Sakauchi F; Nojima M; Mori M; Wakai K; Suzuki S; Tamakoshi A; Ito Y; Watanabe Y; Inaba Y; Tajima K; Nakachi K
Asian Pac J Cancer Prev; 2009 Dec; 10 Suppl():51-5. PubMed ID: 20553082
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B
J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]